CSIEX
Price
$77.25
Change
+$0.46 (+0.60%)
Updated
May 8 closing price
Net Assets
5.69B
RGAGX
Price
$72.82
Change
+$0.54 (+0.75%)
Updated
May 8 closing price
Net Assets
283.8B
Ad is loading...

CSIEX vs RGAGX

Header iconCSIEX vs RGAGX Comparison
Open Charts CSIEX vs RGAGXBanner chart's image
Calvert Equity A
Price$77.25
Change+$0.46 (+0.60%)
VolumeN/A
Net Assets5.69B
American Funds Growth Fund of Amer R6
Price$72.82
Change+$0.54 (+0.75%)
VolumeN/A
Net Assets283.8B
CSIEX vs RGAGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSIEX vs. RGAGX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSIEX is a Buy and RGAGX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 284B vs. CSIEX (5.69B). RGAGX pays higher dividends than CSIEX: RGAGX (0.70) vs CSIEX (0.16). CSIEX was incepted earlier than RGAGX: CSIEX (38 years) vs RGAGX (16 years). CSIEX (0.90) is less costly to investors than RGAGX (0.30). RGAGX is a more actively managed with annual turnover of: 25.00 vs. CSIEX (9.00). RGAGX has a lower initial minimum investment than CSIEX: RGAGX (250) vs CSIEX (1000). RGAGX annual gain was more profitable for investors over the last year : 4.03 vs. CSIEX (-2.94). RGAGX return over 5 years is better than : 46.25 vs. CSIEX (41.55).
CSIEXRGAGXCSIEX / RGAGX
Total Expense Ratio0.900.30300%
Annual Report Gross Expense Ratio0.900.30300%
Fund Existence38 years16 years-
Gain YTD0.222-2.321-10%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets5.69B284B2%
Annual Yield % from dividends0.160.7023%
Returns for 1 year-2.944.03-73%
Returns for 3 years18.0335.2251%
Returns for 5 years41.5546.2590%
Returns for 10 years53.6963.8284%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.450.34
+8.27%
ARKO Corp
VTRS9.090.49
+5.70%
Viatris
TCBI72.612.56
+3.65%
Texas Capital Bancshares
LRMR2.240.07
+3.23%
Larimar Therapeutics
CTXR0.70N/A
+0.29%
Citius Pharmaceuticals Inc